Global Hospital-Acquired Infections Assays Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Hospital-Acquired Infections Assays market size was valued at US$ 5127 million in 2025 and is forecast to a readjusted size of US$ 8208 million by 2032 with a CAGR of 7.0% during review period.
Hospital-acquired infections assays refer to diagnostic tests and assays designed to identify and detect infections that patients may acquire during their stay in healthcare facilities, such as hospitals. These assays play a crucial role in early and accurate diagnosis, enabling healthcare providers to implement timely interventions and prevent the spread of infections within healthcare settings.
The market for hospital-acquired infections assays is driven by the increasing awareness of the importance of infection control in healthcare settings. The assays include a variety of diagnostic tools, such as molecular assays, immunoassays, and microbial culture tests, providing a comprehensive approach to identifying and managing hospital-acquired infections. The need for rapid and accurate diagnostics to reduce the incidence of hospital-acquired infections contributes to the growth of this market.
This report is a detailed and comprehensive analysis for global Hospital-Acquired Infections Assays market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Global Hospital-Acquired Infections Assays market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Hospital-Acquired Infections Assays market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Hospital-Acquired Infections Assays market shares of main players, in revenue ($ Million), 2021-2026
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Chapter 2, to profile the top players of Hospital-Acquired Infections Assays, with revenue, gross margin, and global market share of Hospital-Acquired Infections Assays from 2021 to 2026.
Chapter 3, the Hospital-Acquired Infections Assays competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Hospital-Acquired Infections Assays market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Hospital-Acquired Infections Assays.
Chapter 13, to describe Hospital-Acquired Infections Assays research findings and conclusion.
Hospital-acquired infections assays refer to diagnostic tests and assays designed to identify and detect infections that patients may acquire during their stay in healthcare facilities, such as hospitals. These assays play a crucial role in early and accurate diagnosis, enabling healthcare providers to implement timely interventions and prevent the spread of infections within healthcare settings.
The market for hospital-acquired infections assays is driven by the increasing awareness of the importance of infection control in healthcare settings. The assays include a variety of diagnostic tools, such as molecular assays, immunoassays, and microbial culture tests, providing a comprehensive approach to identifying and managing hospital-acquired infections. The need for rapid and accurate diagnostics to reduce the incidence of hospital-acquired infections contributes to the growth of this market.
This report is a detailed and comprehensive analysis for global Hospital-Acquired Infections Assays market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Hospital-Acquired Infections Assays market size and forecasts, in consumption value ($ Million), 2021-2032Global Hospital-Acquired Infections Assays market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Hospital-Acquired Infections Assays market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Hospital-Acquired Infections Assays market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Hospital-Acquired Infections Assays
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Hospital-Acquired Infections Assays market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.Market segment by Type
- Blood Tests
- Urinalysis
Market segment by Application
- Urinary Tract Infections
- Pneumonia
- Surgical Site Infections
- Bloodstream Infections
- Other Hospital Infections
Market segment by players, this report covers
- BIOMÉRIEUX
- Abbott
- F. Hoffmann-La Roche Ltd.
- Siemens Healthcare Private Limited
- BD (Becton, Dickinson and Company)
- Bioscience, Inc.
- QIAGEN
- Thermo Fisher Scientific Inc.
- Meridian Bioscience, Inc.
- Hologic, Inc.
Market segment by regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
- South America (Brazil, Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Hospital-Acquired Infections Assays product scope, market overview, market estimation caveats and base year.Chapter 2, to profile the top players of Hospital-Acquired Infections Assays, with revenue, gross margin, and global market share of Hospital-Acquired Infections Assays from 2021 to 2026.
Chapter 3, the Hospital-Acquired Infections Assays competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Hospital-Acquired Infections Assays market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Hospital-Acquired Infections Assays.
Chapter 13, to describe Hospital-Acquired Infections Assays research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Hospital-Acquired Infections Assays by Type
1.3.1 Overview: Global Hospital-Acquired Infections Assays Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Hospital-Acquired Infections Assays Consumption Value Market Share by Type in 2025
1.3.3 Blood Tests
1.3.4 Urinalysis
1.4 Global Hospital-Acquired Infections Assays Market by Application
1.4.1 Overview: Global Hospital-Acquired Infections Assays Market Size by Application: 2021 Versus 2025 Versus 2032
1.4.2 Urinary Tract Infections
1.4.3 Pneumonia
1.4.4 Surgical Site Infections
1.4.5 Bloodstream Infections
1.4.6 Other Hospital Infections
1.5 Global Hospital-Acquired Infections Assays Market Size & Forecast
1.6 Global Hospital-Acquired Infections Assays Market Size and Forecast by Region
1.6.1 Global Hospital-Acquired Infections Assays Market Size by Region: 2021 VS 2025 VS 2032
1.6.2 Global Hospital-Acquired Infections Assays Market Size by Region, (2021-2032)
1.6.3 North America Hospital-Acquired Infections Assays Market Size and Prospect (2021-2032)
1.6.4 Europe Hospital-Acquired Infections Assays Market Size and Prospect (2021-2032)
1.6.5 Asia-Pacific Hospital-Acquired Infections Assays Market Size and Prospect (2021-2032)
1.6.6 South America Hospital-Acquired Infections Assays Market Size and Prospect (2021-2032)
1.6.7 Middle East & Africa Hospital-Acquired Infections Assays Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 BIOMÉRIEUX
2.1.1 BIOMÉRIEUX Details
2.1.2 BIOMÉRIEUX Major Business
2.1.3 BIOMÉRIEUX Hospital-Acquired Infections Assays Product and Solutions
2.1.4 BIOMÉRIEUX Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 BIOMÉRIEUX Recent Developments and Future Plans
2.2 Abbott
2.2.1 Abbott Details
2.2.2 Abbott Major Business
2.2.3 Abbott Hospital-Acquired Infections Assays Product and Solutions
2.2.4 Abbott Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Abbott Recent Developments and Future Plans
2.3 F. Hoffmann-La Roche Ltd.
2.3.1 F. Hoffmann-La Roche Ltd. Details
2.3.2 F. Hoffmann-La Roche Ltd. Major Business
2.3.3 F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Product and Solutions
2.3.4 F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
2.4 Siemens Healthcare Private Limited
2.4.1 Siemens Healthcare Private Limited Details
2.4.2 Siemens Healthcare Private Limited Major Business
2.4.3 Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Product and Solutions
2.4.4 Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Siemens Healthcare Private Limited Recent Developments and Future Plans
2.5 BD (Becton, Dickinson and Company)
2.5.1 BD (Becton, Dickinson and Company) Details
2.5.2 BD (Becton, Dickinson and Company) Major Business
2.5.3 BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Product and Solutions
2.5.4 BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 BD (Becton, Dickinson and Company) Recent Developments and Future Plans
2.6 Bioscience, Inc.
2.6.1 Bioscience, Inc. Details
2.6.2 Bioscience, Inc. Major Business
2.6.3 Bioscience, Inc. Hospital-Acquired Infections Assays Product and Solutions
2.6.4 Bioscience, Inc. Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Bioscience, Inc. Recent Developments and Future Plans
2.7 QIAGEN
2.7.1 QIAGEN Details
2.7.2 QIAGEN Major Business
2.7.3 QIAGEN Hospital-Acquired Infections Assays Product and Solutions
2.7.4 QIAGEN Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 QIAGEN Recent Developments and Future Plans
2.8 Thermo Fisher Scientific Inc.
2.8.1 Thermo Fisher Scientific Inc. Details
2.8.2 Thermo Fisher Scientific Inc. Major Business
2.8.3 Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Product and Solutions
2.8.4 Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
2.9 Meridian Bioscience, Inc.
2.9.1 Meridian Bioscience, Inc. Details
2.9.2 Meridian Bioscience, Inc. Major Business
2.9.3 Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Product and Solutions
2.9.4 Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Meridian Bioscience, Inc. Recent Developments and Future Plans
2.10 Hologic, Inc.
2.10.1 Hologic, Inc. Details
2.10.2 Hologic, Inc. Major Business
2.10.3 Hologic, Inc. Hospital-Acquired Infections Assays Product and Solutions
2.10.4 Hologic, Inc. Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Hologic, Inc. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Hospital-Acquired Infections Assays Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Hospital-Acquired Infections Assays by Company Revenue
3.2.2 Top 3 Hospital-Acquired Infections Assays Players Market Share in 2025
3.2.3 Top 6 Hospital-Acquired Infections Assays Players Market Share in 2025
3.3 Hospital-Acquired Infections Assays Market: Overall Company Footprint Analysis
3.3.1 Hospital-Acquired Infections Assays Market: Region Footprint
3.3.2 Hospital-Acquired Infections Assays Market: Company Product Type Footprint
3.3.3 Hospital-Acquired Infections Assays Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Hospital-Acquired Infections Assays Consumption Value and Market Share by Type (2021-2026)
4.2 Global Hospital-Acquired Infections Assays Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Hospital-Acquired Infections Assays Consumption Value Market Share by Application (2021-2026)
5.2 Global Hospital-Acquired Infections Assays Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Hospital-Acquired Infections Assays Consumption Value by Type (2021-2032)
6.2 North America Hospital-Acquired Infections Assays Market Size by Application (2021-2032)
6.3 North America Hospital-Acquired Infections Assays Market Size by Country
6.3.1 North America Hospital-Acquired Infections Assays Consumption Value by Country (2021-2032)
6.3.2 United States Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
6.3.3 Canada Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
6.3.4 Mexico Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Hospital-Acquired Infections Assays Consumption Value by Type (2021-2032)
7.2 Europe Hospital-Acquired Infections Assays Consumption Value by Application (2021-2032)
7.3 Europe Hospital-Acquired Infections Assays Market Size by Country
7.3.1 Europe Hospital-Acquired Infections Assays Consumption Value by Country (2021-2032)
7.3.2 Germany Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
7.3.3 France Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
7.3.5 Russia Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
7.3.6 Italy Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Hospital-Acquired Infections Assays Market Size by Region
8.3.1 Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Region (2021-2032)
8.3.2 China Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
8.3.3 Japan Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
8.3.4 South Korea Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
8.3.5 India Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
8.3.7 Australia Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Hospital-Acquired Infections Assays Consumption Value by Type (2021-2032)
9.2 South America Hospital-Acquired Infections Assays Consumption Value by Application (2021-2032)
9.3 South America Hospital-Acquired Infections Assays Market Size by Country
9.3.1 South America Hospital-Acquired Infections Assays Consumption Value by Country (2021-2032)
9.3.2 Brazil Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
9.3.3 Argentina Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Hospital-Acquired Infections Assays Market Size by Country
10.3.1 Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Country (2021-2032)
10.3.2 Turkey Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
10.3.4 UAE Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Hospital-Acquired Infections Assays Market Drivers
11.2 Hospital-Acquired Infections Assays Market Restraints
11.3 Hospital-Acquired Infections Assays Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Hospital-Acquired Infections Assays Industry Chain
12.2 Hospital-Acquired Infections Assays Upstream Analysis
12.3 Hospital-Acquired Infections Assays Midstream Analysis
12.4 Hospital-Acquired Infections Assays Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Hospital-Acquired Infections Assays by Type
1.3.1 Overview: Global Hospital-Acquired Infections Assays Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Hospital-Acquired Infections Assays Consumption Value Market Share by Type in 2025
1.3.3 Blood Tests
1.3.4 Urinalysis
1.4 Global Hospital-Acquired Infections Assays Market by Application
1.4.1 Overview: Global Hospital-Acquired Infections Assays Market Size by Application: 2021 Versus 2025 Versus 2032
1.4.2 Urinary Tract Infections
1.4.3 Pneumonia
1.4.4 Surgical Site Infections
1.4.5 Bloodstream Infections
1.4.6 Other Hospital Infections
1.5 Global Hospital-Acquired Infections Assays Market Size & Forecast
1.6 Global Hospital-Acquired Infections Assays Market Size and Forecast by Region
1.6.1 Global Hospital-Acquired Infections Assays Market Size by Region: 2021 VS 2025 VS 2032
1.6.2 Global Hospital-Acquired Infections Assays Market Size by Region, (2021-2032)
1.6.3 North America Hospital-Acquired Infections Assays Market Size and Prospect (2021-2032)
1.6.4 Europe Hospital-Acquired Infections Assays Market Size and Prospect (2021-2032)
1.6.5 Asia-Pacific Hospital-Acquired Infections Assays Market Size and Prospect (2021-2032)
1.6.6 South America Hospital-Acquired Infections Assays Market Size and Prospect (2021-2032)
1.6.7 Middle East & Africa Hospital-Acquired Infections Assays Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 BIOMÉRIEUX
2.1.1 BIOMÉRIEUX Details
2.1.2 BIOMÉRIEUX Major Business
2.1.3 BIOMÉRIEUX Hospital-Acquired Infections Assays Product and Solutions
2.1.4 BIOMÉRIEUX Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 BIOMÉRIEUX Recent Developments and Future Plans
2.2 Abbott
2.2.1 Abbott Details
2.2.2 Abbott Major Business
2.2.3 Abbott Hospital-Acquired Infections Assays Product and Solutions
2.2.4 Abbott Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Abbott Recent Developments and Future Plans
2.3 F. Hoffmann-La Roche Ltd.
2.3.1 F. Hoffmann-La Roche Ltd. Details
2.3.2 F. Hoffmann-La Roche Ltd. Major Business
2.3.3 F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Product and Solutions
2.3.4 F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
2.4 Siemens Healthcare Private Limited
2.4.1 Siemens Healthcare Private Limited Details
2.4.2 Siemens Healthcare Private Limited Major Business
2.4.3 Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Product and Solutions
2.4.4 Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Siemens Healthcare Private Limited Recent Developments and Future Plans
2.5 BD (Becton, Dickinson and Company)
2.5.1 BD (Becton, Dickinson and Company) Details
2.5.2 BD (Becton, Dickinson and Company) Major Business
2.5.3 BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Product and Solutions
2.5.4 BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 BD (Becton, Dickinson and Company) Recent Developments and Future Plans
2.6 Bioscience, Inc.
2.6.1 Bioscience, Inc. Details
2.6.2 Bioscience, Inc. Major Business
2.6.3 Bioscience, Inc. Hospital-Acquired Infections Assays Product and Solutions
2.6.4 Bioscience, Inc. Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Bioscience, Inc. Recent Developments and Future Plans
2.7 QIAGEN
2.7.1 QIAGEN Details
2.7.2 QIAGEN Major Business
2.7.3 QIAGEN Hospital-Acquired Infections Assays Product and Solutions
2.7.4 QIAGEN Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 QIAGEN Recent Developments and Future Plans
2.8 Thermo Fisher Scientific Inc.
2.8.1 Thermo Fisher Scientific Inc. Details
2.8.2 Thermo Fisher Scientific Inc. Major Business
2.8.3 Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Product and Solutions
2.8.4 Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
2.9 Meridian Bioscience, Inc.
2.9.1 Meridian Bioscience, Inc. Details
2.9.2 Meridian Bioscience, Inc. Major Business
2.9.3 Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Product and Solutions
2.9.4 Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Meridian Bioscience, Inc. Recent Developments and Future Plans
2.10 Hologic, Inc.
2.10.1 Hologic, Inc. Details
2.10.2 Hologic, Inc. Major Business
2.10.3 Hologic, Inc. Hospital-Acquired Infections Assays Product and Solutions
2.10.4 Hologic, Inc. Hospital-Acquired Infections Assays Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Hologic, Inc. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Hospital-Acquired Infections Assays Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Hospital-Acquired Infections Assays by Company Revenue
3.2.2 Top 3 Hospital-Acquired Infections Assays Players Market Share in 2025
3.2.3 Top 6 Hospital-Acquired Infections Assays Players Market Share in 2025
3.3 Hospital-Acquired Infections Assays Market: Overall Company Footprint Analysis
3.3.1 Hospital-Acquired Infections Assays Market: Region Footprint
3.3.2 Hospital-Acquired Infections Assays Market: Company Product Type Footprint
3.3.3 Hospital-Acquired Infections Assays Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Hospital-Acquired Infections Assays Consumption Value and Market Share by Type (2021-2026)
4.2 Global Hospital-Acquired Infections Assays Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Hospital-Acquired Infections Assays Consumption Value Market Share by Application (2021-2026)
5.2 Global Hospital-Acquired Infections Assays Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Hospital-Acquired Infections Assays Consumption Value by Type (2021-2032)
6.2 North America Hospital-Acquired Infections Assays Market Size by Application (2021-2032)
6.3 North America Hospital-Acquired Infections Assays Market Size by Country
6.3.1 North America Hospital-Acquired Infections Assays Consumption Value by Country (2021-2032)
6.3.2 United States Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
6.3.3 Canada Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
6.3.4 Mexico Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Hospital-Acquired Infections Assays Consumption Value by Type (2021-2032)
7.2 Europe Hospital-Acquired Infections Assays Consumption Value by Application (2021-2032)
7.3 Europe Hospital-Acquired Infections Assays Market Size by Country
7.3.1 Europe Hospital-Acquired Infections Assays Consumption Value by Country (2021-2032)
7.3.2 Germany Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
7.3.3 France Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
7.3.5 Russia Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
7.3.6 Italy Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Hospital-Acquired Infections Assays Market Size by Region
8.3.1 Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Region (2021-2032)
8.3.2 China Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
8.3.3 Japan Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
8.3.4 South Korea Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
8.3.5 India Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
8.3.7 Australia Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Hospital-Acquired Infections Assays Consumption Value by Type (2021-2032)
9.2 South America Hospital-Acquired Infections Assays Consumption Value by Application (2021-2032)
9.3 South America Hospital-Acquired Infections Assays Market Size by Country
9.3.1 South America Hospital-Acquired Infections Assays Consumption Value by Country (2021-2032)
9.3.2 Brazil Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
9.3.3 Argentina Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Hospital-Acquired Infections Assays Market Size by Country
10.3.1 Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Country (2021-2032)
10.3.2 Turkey Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
10.3.4 UAE Hospital-Acquired Infections Assays Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Hospital-Acquired Infections Assays Market Drivers
11.2 Hospital-Acquired Infections Assays Market Restraints
11.3 Hospital-Acquired Infections Assays Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Hospital-Acquired Infections Assays Industry Chain
12.2 Hospital-Acquired Infections Assays Upstream Analysis
12.3 Hospital-Acquired Infections Assays Midstream Analysis
12.4 Hospital-Acquired Infections Assays Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Hospital-Acquired Infections Assays Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Hospital-Acquired Infections Assays Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Global Hospital-Acquired Infections Assays Consumption Value by Region (2021-2026) & (USD Million)
Table 4. Global Hospital-Acquired Infections Assays Consumption Value by Region (2027-2032) & (USD Million)
Table 5. BIOMÉRIEUX Company Information, Head Office, and Major Competitors
Table 6. BIOMÉRIEUX Major Business
Table 7. BIOMÉRIEUX Hospital-Acquired Infections Assays Product and Solutions
Table 8. BIOMÉRIEUX Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. BIOMÉRIEUX Recent Developments and Future Plans
Table 10. Abbott Company Information, Head Office, and Major Competitors
Table 11. Abbott Major Business
Table 12. Abbott Hospital-Acquired Infections Assays Product and Solutions
Table 13. Abbott Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Abbott Recent Developments and Future Plans
Table 15. F. Hoffmann-La Roche Ltd. Company Information, Head Office, and Major Competitors
Table 16. F. Hoffmann-La Roche Ltd. Major Business
Table 17. F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Product and Solutions
Table 18. F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Siemens Healthcare Private Limited Company Information, Head Office, and Major Competitors
Table 20. Siemens Healthcare Private Limited Major Business
Table 21. Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Product and Solutions
Table 22. Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. Siemens Healthcare Private Limited Recent Developments and Future Plans
Table 24. BD (Becton, Dickinson and Company) Company Information, Head Office, and Major Competitors
Table 25. BD (Becton, Dickinson and Company) Major Business
Table 26. BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Product and Solutions
Table 27. BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. BD (Becton, Dickinson and Company) Recent Developments and Future Plans
Table 29. Bioscience, Inc. Company Information, Head Office, and Major Competitors
Table 30. Bioscience, Inc. Major Business
Table 31. Bioscience, Inc. Hospital-Acquired Infections Assays Product and Solutions
Table 32. Bioscience, Inc. Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. Bioscience, Inc. Recent Developments and Future Plans
Table 34. QIAGEN Company Information, Head Office, and Major Competitors
Table 35. QIAGEN Major Business
Table 36. QIAGEN Hospital-Acquired Infections Assays Product and Solutions
Table 37. QIAGEN Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. QIAGEN Recent Developments and Future Plans
Table 39. Thermo Fisher Scientific Inc. Company Information, Head Office, and Major Competitors
Table 40. Thermo Fisher Scientific Inc. Major Business
Table 41. Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Product and Solutions
Table 42. Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. Thermo Fisher Scientific Inc. Recent Developments and Future Plans
Table 44. Meridian Bioscience, Inc. Company Information, Head Office, and Major Competitors
Table 45. Meridian Bioscience, Inc. Major Business
Table 46. Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Product and Solutions
Table 47. Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. Meridian Bioscience, Inc. Recent Developments and Future Plans
Table 49. Hologic, Inc. Company Information, Head Office, and Major Competitors
Table 50. Hologic, Inc. Major Business
Table 51. Hologic, Inc. Hospital-Acquired Infections Assays Product and Solutions
Table 52. Hologic, Inc. Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. Hologic, Inc. Recent Developments and Future Plans
Table 54. Global Hospital-Acquired Infections Assays Revenue (USD Million) by Players (2021-2026)
Table 55. Global Hospital-Acquired Infections Assays Revenue Share by Players (2021-2026)
Table 56. Breakdown of Hospital-Acquired Infections Assays by Company Type (Tier 1, Tier 2, and Tier 3)
Table 57. Market Position of Players in Hospital-Acquired Infections Assays, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 58. Head Office of Key Hospital-Acquired Infections Assays Players
Table 59. Hospital-Acquired Infections Assays Market: Company Product Type Footprint
Table 60. Hospital-Acquired Infections Assays Market: Company Product Application Footprint
Table 61. Hospital-Acquired Infections Assays New Market Entrants and Barriers to Market Entry
Table 62. Hospital-Acquired Infections Assays Mergers, Acquisition, Agreements, and Collaborations
Table 63. Global Hospital-Acquired Infections Assays Consumption Value (USD Million) by Type (2021-2026)
Table 64. Global Hospital-Acquired Infections Assays Consumption Value Share by Type (2021-2026)
Table 65. Global Hospital-Acquired Infections Assays Consumption Value Forecast by Type (2027-2032)
Table 66. Global Hospital-Acquired Infections Assays Consumption Value by Application (2021-2026)
Table 67. Global Hospital-Acquired Infections Assays Consumption Value Forecast by Application (2027-2032)
Table 68. North America Hospital-Acquired Infections Assays Consumption Value by Type (2021-2026) & (USD Million)
Table 69. North America Hospital-Acquired Infections Assays Consumption Value by Type (2027-2032) & (USD Million)
Table 70. North America Hospital-Acquired Infections Assays Consumption Value by Application (2021-2026) & (USD Million)
Table 71. North America Hospital-Acquired Infections Assays Consumption Value by Application (2027-2032) & (USD Million)
Table 72. North America Hospital-Acquired Infections Assays Consumption Value by Country (2021-2026) & (USD Million)
Table 73. North America Hospital-Acquired Infections Assays Consumption Value by Country (2027-2032) & (USD Million)
Table 74. Europe Hospital-Acquired Infections Assays Consumption Value by Type (2021-2026) & (USD Million)
Table 75. Europe Hospital-Acquired Infections Assays Consumption Value by Type (2027-2032) & (USD Million)
Table 76. Europe Hospital-Acquired Infections Assays Consumption Value by Application (2021-2026) & (USD Million)
Table 77. Europe Hospital-Acquired Infections Assays Consumption Value by Application (2027-2032) & (USD Million)
Table 78. Europe Hospital-Acquired Infections Assays Consumption Value by Country (2021-2026) & (USD Million)
Table 79. Europe Hospital-Acquired Infections Assays Consumption Value by Country (2027-2032) & (USD Million)
Table 80. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Type (2021-2026) & (USD Million)
Table 81. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Type (2027-2032) & (USD Million)
Table 82. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Application (2021-2026) & (USD Million)
Table 83. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Application (2027-2032) & (USD Million)
Table 84. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Region (2021-2026) & (USD Million)
Table 85. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Region (2027-2032) & (USD Million)
Table 86. South America Hospital-Acquired Infections Assays Consumption Value by Type (2021-2026) & (USD Million)
Table 87. South America Hospital-Acquired Infections Assays Consumption Value by Type (2027-2032) & (USD Million)
Table 88. South America Hospital-Acquired Infections Assays Consumption Value by Application (2021-2026) & (USD Million)
Table 89. South America Hospital-Acquired Infections Assays Consumption Value by Application (2027-2032) & (USD Million)
Table 90. South America Hospital-Acquired Infections Assays Consumption Value by Country (2021-2026) & (USD Million)
Table 91. South America Hospital-Acquired Infections Assays Consumption Value by Country (2027-2032) & (USD Million)
Table 92. Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Type (2021-2026) & (USD Million)
Table 93. Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Type (2027-2032) & (USD Million)
Table 94. Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Application (2021-2026) & (USD Million)
Table 95. Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Application (2027-2032) & (USD Million)
Table 96. Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Country (2021-2026) & (USD Million)
Table 97. Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Country (2027-2032) & (USD Million)
Table 98. Global Key Players of Hospital-Acquired Infections Assays Upstream (Raw Materials)
Table 99. Global Hospital-Acquired Infections Assays Typical Customers
Table 1. Global Hospital-Acquired Infections Assays Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Hospital-Acquired Infections Assays Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Global Hospital-Acquired Infections Assays Consumption Value by Region (2021-2026) & (USD Million)
Table 4. Global Hospital-Acquired Infections Assays Consumption Value by Region (2027-2032) & (USD Million)
Table 5. BIOMÉRIEUX Company Information, Head Office, and Major Competitors
Table 6. BIOMÉRIEUX Major Business
Table 7. BIOMÉRIEUX Hospital-Acquired Infections Assays Product and Solutions
Table 8. BIOMÉRIEUX Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. BIOMÉRIEUX Recent Developments and Future Plans
Table 10. Abbott Company Information, Head Office, and Major Competitors
Table 11. Abbott Major Business
Table 12. Abbott Hospital-Acquired Infections Assays Product and Solutions
Table 13. Abbott Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Abbott Recent Developments and Future Plans
Table 15. F. Hoffmann-La Roche Ltd. Company Information, Head Office, and Major Competitors
Table 16. F. Hoffmann-La Roche Ltd. Major Business
Table 17. F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Product and Solutions
Table 18. F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Siemens Healthcare Private Limited Company Information, Head Office, and Major Competitors
Table 20. Siemens Healthcare Private Limited Major Business
Table 21. Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Product and Solutions
Table 22. Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. Siemens Healthcare Private Limited Recent Developments and Future Plans
Table 24. BD (Becton, Dickinson and Company) Company Information, Head Office, and Major Competitors
Table 25. BD (Becton, Dickinson and Company) Major Business
Table 26. BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Product and Solutions
Table 27. BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. BD (Becton, Dickinson and Company) Recent Developments and Future Plans
Table 29. Bioscience, Inc. Company Information, Head Office, and Major Competitors
Table 30. Bioscience, Inc. Major Business
Table 31. Bioscience, Inc. Hospital-Acquired Infections Assays Product and Solutions
Table 32. Bioscience, Inc. Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. Bioscience, Inc. Recent Developments and Future Plans
Table 34. QIAGEN Company Information, Head Office, and Major Competitors
Table 35. QIAGEN Major Business
Table 36. QIAGEN Hospital-Acquired Infections Assays Product and Solutions
Table 37. QIAGEN Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. QIAGEN Recent Developments and Future Plans
Table 39. Thermo Fisher Scientific Inc. Company Information, Head Office, and Major Competitors
Table 40. Thermo Fisher Scientific Inc. Major Business
Table 41. Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Product and Solutions
Table 42. Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. Thermo Fisher Scientific Inc. Recent Developments and Future Plans
Table 44. Meridian Bioscience, Inc. Company Information, Head Office, and Major Competitors
Table 45. Meridian Bioscience, Inc. Major Business
Table 46. Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Product and Solutions
Table 47. Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. Meridian Bioscience, Inc. Recent Developments and Future Plans
Table 49. Hologic, Inc. Company Information, Head Office, and Major Competitors
Table 50. Hologic, Inc. Major Business
Table 51. Hologic, Inc. Hospital-Acquired Infections Assays Product and Solutions
Table 52. Hologic, Inc. Hospital-Acquired Infections Assays Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. Hologic, Inc. Recent Developments and Future Plans
Table 54. Global Hospital-Acquired Infections Assays Revenue (USD Million) by Players (2021-2026)
Table 55. Global Hospital-Acquired Infections Assays Revenue Share by Players (2021-2026)
Table 56. Breakdown of Hospital-Acquired Infections Assays by Company Type (Tier 1, Tier 2, and Tier 3)
Table 57. Market Position of Players in Hospital-Acquired Infections Assays, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 58. Head Office of Key Hospital-Acquired Infections Assays Players
Table 59. Hospital-Acquired Infections Assays Market: Company Product Type Footprint
Table 60. Hospital-Acquired Infections Assays Market: Company Product Application Footprint
Table 61. Hospital-Acquired Infections Assays New Market Entrants and Barriers to Market Entry
Table 62. Hospital-Acquired Infections Assays Mergers, Acquisition, Agreements, and Collaborations
Table 63. Global Hospital-Acquired Infections Assays Consumption Value (USD Million) by Type (2021-2026)
Table 64. Global Hospital-Acquired Infections Assays Consumption Value Share by Type (2021-2026)
Table 65. Global Hospital-Acquired Infections Assays Consumption Value Forecast by Type (2027-2032)
Table 66. Global Hospital-Acquired Infections Assays Consumption Value by Application (2021-2026)
Table 67. Global Hospital-Acquired Infections Assays Consumption Value Forecast by Application (2027-2032)
Table 68. North America Hospital-Acquired Infections Assays Consumption Value by Type (2021-2026) & (USD Million)
Table 69. North America Hospital-Acquired Infections Assays Consumption Value by Type (2027-2032) & (USD Million)
Table 70. North America Hospital-Acquired Infections Assays Consumption Value by Application (2021-2026) & (USD Million)
Table 71. North America Hospital-Acquired Infections Assays Consumption Value by Application (2027-2032) & (USD Million)
Table 72. North America Hospital-Acquired Infections Assays Consumption Value by Country (2021-2026) & (USD Million)
Table 73. North America Hospital-Acquired Infections Assays Consumption Value by Country (2027-2032) & (USD Million)
Table 74. Europe Hospital-Acquired Infections Assays Consumption Value by Type (2021-2026) & (USD Million)
Table 75. Europe Hospital-Acquired Infections Assays Consumption Value by Type (2027-2032) & (USD Million)
Table 76. Europe Hospital-Acquired Infections Assays Consumption Value by Application (2021-2026) & (USD Million)
Table 77. Europe Hospital-Acquired Infections Assays Consumption Value by Application (2027-2032) & (USD Million)
Table 78. Europe Hospital-Acquired Infections Assays Consumption Value by Country (2021-2026) & (USD Million)
Table 79. Europe Hospital-Acquired Infections Assays Consumption Value by Country (2027-2032) & (USD Million)
Table 80. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Type (2021-2026) & (USD Million)
Table 81. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Type (2027-2032) & (USD Million)
Table 82. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Application (2021-2026) & (USD Million)
Table 83. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Application (2027-2032) & (USD Million)
Table 84. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Region (2021-2026) & (USD Million)
Table 85. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value by Region (2027-2032) & (USD Million)
Table 86. South America Hospital-Acquired Infections Assays Consumption Value by Type (2021-2026) & (USD Million)
Table 87. South America Hospital-Acquired Infections Assays Consumption Value by Type (2027-2032) & (USD Million)
Table 88. South America Hospital-Acquired Infections Assays Consumption Value by Application (2021-2026) & (USD Million)
Table 89. South America Hospital-Acquired Infections Assays Consumption Value by Application (2027-2032) & (USD Million)
Table 90. South America Hospital-Acquired Infections Assays Consumption Value by Country (2021-2026) & (USD Million)
Table 91. South America Hospital-Acquired Infections Assays Consumption Value by Country (2027-2032) & (USD Million)
Table 92. Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Type (2021-2026) & (USD Million)
Table 93. Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Type (2027-2032) & (USD Million)
Table 94. Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Application (2021-2026) & (USD Million)
Table 95. Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Application (2027-2032) & (USD Million)
Table 96. Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Country (2021-2026) & (USD Million)
Table 97. Middle East & Africa Hospital-Acquired Infections Assays Consumption Value by Country (2027-2032) & (USD Million)
Table 98. Global Key Players of Hospital-Acquired Infections Assays Upstream (Raw Materials)
Table 99. Global Hospital-Acquired Infections Assays Typical Customers
LIST OF FIGURES
Figure 1. Hospital-Acquired Infections Assays Picture
Figure 2. Global Hospital-Acquired Infections Assays Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Hospital-Acquired Infections Assays Consumption Value Market Share by Type in 2025
Figure 4. Blood Tests
Figure 5. Urinalysis
Figure 6. Global Hospital-Acquired Infections Assays Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 7. Hospital-Acquired Infections Assays Consumption Value Market Share by Application in 2025
Figure 8. Urinary Tract Infections Picture
Figure 9. Pneumonia Picture
Figure 10. Surgical Site Infections Picture
Figure 11. Bloodstream Infections Picture
Figure 12. Other Hospital Infections Picture
Figure 13. Global Hospital-Acquired Infections Assays Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 14. Global Hospital-Acquired Infections Assays Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 15. Global Market Hospital-Acquired Infections Assays Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 16. Global Hospital-Acquired Infections Assays Consumption Value Market Share by Region (2021-2032)
Figure 17. Global Hospital-Acquired Infections Assays Consumption Value Market Share by Region in 2025
Figure 18. North America Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 20. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 21. South America Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 22. Middle East & Africa Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 23. Company Three Recent Developments and Future Plans
Figure 24. Global Hospital-Acquired Infections Assays Revenue Share by Players in 2025
Figure 25. Hospital-Acquired Infections Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 26. Market Share of Hospital-Acquired Infections Assays by Player Revenue in 2025
Figure 27. Top 3 Hospital-Acquired Infections Assays Players Market Share in 2025
Figure 28. Top 6 Hospital-Acquired Infections Assays Players Market Share in 2025
Figure 29. Global Hospital-Acquired Infections Assays Consumption Value Share by Type (2021-2026)
Figure 30. Global Hospital-Acquired Infections Assays Market Share Forecast by Type (2027-2032)
Figure 31. Global Hospital-Acquired Infections Assays Consumption Value Share by Application (2021-2026)
Figure 32. Global Hospital-Acquired Infections Assays Market Share Forecast by Application (2027-2032)
Figure 33. North America Hospital-Acquired Infections Assays Consumption Value Market Share by Type (2021-2032)
Figure 34. North America Hospital-Acquired Infections Assays Consumption Value Market Share by Application (2021-2032)
Figure 35. North America Hospital-Acquired Infections Assays Consumption Value Market Share by Country (2021-2032)
Figure 36. United States Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 37. Canada Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 38. Mexico Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 39. Europe Hospital-Acquired Infections Assays Consumption Value Market Share by Type (2021-2032)
Figure 40. Europe Hospital-Acquired Infections Assays Consumption Value Market Share by Application (2021-2032)
Figure 41. Europe Hospital-Acquired Infections Assays Consumption Value Market Share by Country (2021-2032)
Figure 42. Germany Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 43. France Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 44. United Kingdom Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 45. Russia Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 46. Italy Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 47. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value Market Share by Type (2021-2032)
Figure 48. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value Market Share by Application (2021-2032)
Figure 49. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value Market Share by Region (2021-2032)
Figure 50. China Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 51. Japan Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 52. South Korea Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 53. India Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 54. Southeast Asia Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 55. Australia Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 56. South America Hospital-Acquired Infections Assays Consumption Value Market Share by Type (2021-2032)
Figure 57. South America Hospital-Acquired Infections Assays Consumption Value Market Share by Application (2021-2032)
Figure 58. South America Hospital-Acquired Infections Assays Consumption Value Market Share by Country (2021-2032)
Figure 59. Brazil Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 60. Argentina Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 61. Middle East & Africa Hospital-Acquired Infections Assays Consumption Value Market Share by Type (2021-2032)
Figure 62. Middle East & Africa Hospital-Acquired Infections Assays Consumption Value Market Share by Application (2021-2032)
Figure 63. Middle East & Africa Hospital-Acquired Infections Assays Consumption Value Market Share by Country (2021-2032)
Figure 64. Turkey Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 65. Saudi Arabia Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 66. UAE Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 67. Hospital-Acquired Infections Assays Market Drivers
Figure 68. Hospital-Acquired Infections Assays Market Restraints
Figure 69. Hospital-Acquired Infections Assays Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Hospital-Acquired Infections Assays Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Hospital-Acquired Infections Assays Picture
Figure 2. Global Hospital-Acquired Infections Assays Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Hospital-Acquired Infections Assays Consumption Value Market Share by Type in 2025
Figure 4. Blood Tests
Figure 5. Urinalysis
Figure 6. Global Hospital-Acquired Infections Assays Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 7. Hospital-Acquired Infections Assays Consumption Value Market Share by Application in 2025
Figure 8. Urinary Tract Infections Picture
Figure 9. Pneumonia Picture
Figure 10. Surgical Site Infections Picture
Figure 11. Bloodstream Infections Picture
Figure 12. Other Hospital Infections Picture
Figure 13. Global Hospital-Acquired Infections Assays Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 14. Global Hospital-Acquired Infections Assays Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 15. Global Market Hospital-Acquired Infections Assays Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 16. Global Hospital-Acquired Infections Assays Consumption Value Market Share by Region (2021-2032)
Figure 17. Global Hospital-Acquired Infections Assays Consumption Value Market Share by Region in 2025
Figure 18. North America Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 20. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 21. South America Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 22. Middle East & Africa Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 23. Company Three Recent Developments and Future Plans
Figure 24. Global Hospital-Acquired Infections Assays Revenue Share by Players in 2025
Figure 25. Hospital-Acquired Infections Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 26. Market Share of Hospital-Acquired Infections Assays by Player Revenue in 2025
Figure 27. Top 3 Hospital-Acquired Infections Assays Players Market Share in 2025
Figure 28. Top 6 Hospital-Acquired Infections Assays Players Market Share in 2025
Figure 29. Global Hospital-Acquired Infections Assays Consumption Value Share by Type (2021-2026)
Figure 30. Global Hospital-Acquired Infections Assays Market Share Forecast by Type (2027-2032)
Figure 31. Global Hospital-Acquired Infections Assays Consumption Value Share by Application (2021-2026)
Figure 32. Global Hospital-Acquired Infections Assays Market Share Forecast by Application (2027-2032)
Figure 33. North America Hospital-Acquired Infections Assays Consumption Value Market Share by Type (2021-2032)
Figure 34. North America Hospital-Acquired Infections Assays Consumption Value Market Share by Application (2021-2032)
Figure 35. North America Hospital-Acquired Infections Assays Consumption Value Market Share by Country (2021-2032)
Figure 36. United States Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 37. Canada Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 38. Mexico Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 39. Europe Hospital-Acquired Infections Assays Consumption Value Market Share by Type (2021-2032)
Figure 40. Europe Hospital-Acquired Infections Assays Consumption Value Market Share by Application (2021-2032)
Figure 41. Europe Hospital-Acquired Infections Assays Consumption Value Market Share by Country (2021-2032)
Figure 42. Germany Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 43. France Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 44. United Kingdom Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 45. Russia Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 46. Italy Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 47. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value Market Share by Type (2021-2032)
Figure 48. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value Market Share by Application (2021-2032)
Figure 49. Asia-Pacific Hospital-Acquired Infections Assays Consumption Value Market Share by Region (2021-2032)
Figure 50. China Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 51. Japan Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 52. South Korea Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 53. India Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 54. Southeast Asia Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 55. Australia Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 56. South America Hospital-Acquired Infections Assays Consumption Value Market Share by Type (2021-2032)
Figure 57. South America Hospital-Acquired Infections Assays Consumption Value Market Share by Application (2021-2032)
Figure 58. South America Hospital-Acquired Infections Assays Consumption Value Market Share by Country (2021-2032)
Figure 59. Brazil Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 60. Argentina Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 61. Middle East & Africa Hospital-Acquired Infections Assays Consumption Value Market Share by Type (2021-2032)
Figure 62. Middle East & Africa Hospital-Acquired Infections Assays Consumption Value Market Share by Application (2021-2032)
Figure 63. Middle East & Africa Hospital-Acquired Infections Assays Consumption Value Market Share by Country (2021-2032)
Figure 64. Turkey Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 65. Saudi Arabia Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 66. UAE Hospital-Acquired Infections Assays Consumption Value (2021-2032) & (USD Million)
Figure 67. Hospital-Acquired Infections Assays Market Drivers
Figure 68. Hospital-Acquired Infections Assays Market Restraints
Figure 69. Hospital-Acquired Infections Assays Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Hospital-Acquired Infections Assays Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
